BUPIVACAINE ACCORD 2.5 mg/ml, solution for injection bottle, 20 ml
Active ingredients: Bupivacaine hydrochloride, Bupivacaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injectionbottle, 20 mlinfiltration;intraarticulaire;péridurale;périneurale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BUPIVACAINE ACCORD 2,5 mg/mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- infiltration;intraarticulaire;péridurale;périneurale
- Presentation description
- 1 flacon(s) en verre de 20 ml avec capsule amovible orange
- Marketing authorisation holder
- ACCORD HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Apr 2022
- Prescription and dispensing conditions
- Prescription only, hospital use
- List II: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63699439CIP75501964CIP133400955019640Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BUPIVACAÏNE (CHLORHYDRATE DE) MONOHYDRATÉsolution | — | SA |
| CHLORHYDRATE DE BUPIVACAÏNE ANHYDREsolution | 2,5 mg · 1 mL | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.